P

PharmaResearch Co Ltd
KOSDAQ:214450

Watchlist Manager
PharmaResearch Co Ltd
KOSDAQ:214450
Watchlist
Price: 209 500 KRW -4.34% Market Closed
Market Cap: 2.2T KRW
Have any thoughts about
PharmaResearch Co Ltd?
Write Note

PharmaResearch Co Ltd
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

PharmaResearch Co Ltd
Additional Paid In Capital Peer Comparison

Comparables:
068270
302440
H
145020
N
007390
196170

Competitive Additional Paid In Capital Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
P
PharmaResearch Co Ltd
KOSDAQ:214450
Additional Paid In Capital
â‚©180.6B
CAGR 3-Years
9%
CAGR 5-Years
8%
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Additional Paid In Capital
â‚©14.8T
CAGR 3-Years
159%
CAGR 5-Years
79%
CAGR 10-Years
44%
SK Bioscience Co Ltd
KRX:302440
Additional Paid In Capital
â‚©1.2T
CAGR 3-Years
86%
CAGR 5-Years
42%
CAGR 10-Years
N/A
H
Hugel Inc
KOSDAQ:145020
Additional Paid In Capital
â‚©395.3B
CAGR 3-Years
6%
CAGR 5-Years
120%
CAGR 10-Years
N/A
N
NatureCell Co Ltd
KOSDAQ:007390
Additional Paid In Capital
â‚©99.9B
CAGR 3-Years
25%
CAGR 5-Years
39%
CAGR 10-Years
16%
Alteogen Inc
KOSDAQ:196170
Additional Paid In Capital
â‚©121.7B
CAGR 3-Years
-11%
CAGR 5-Years
11%
CAGR 10-Years
N/A

See Also

What is PharmaResearch Co Ltd's Additional Paid In Capital?
Additional Paid In Capital
180.6B KRW

Based on the financial report for Jun 30, 2024, PharmaResearch Co Ltd's Additional Paid In Capital amounts to 180.6B KRW.

What is PharmaResearch Co Ltd's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 5Y
8%

Over the last year, the Additional Paid In Capital growth was 6%. The average annual Additional Paid In Capital growth rates for PharmaResearch Co Ltd have been 9% over the past three years , 8% over the past five years .

Back to Top